DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Tejnaksh Healthcare Ltd (TEJNAKSH) share price today?

Tejnaksh Healthcare Ltd (TEJNAKSH) is trading at ₹14.4 on the BSE, up 0.84% on the day. Source: DocStoX.

What is the PE ratio of Tejnaksh Healthcare Ltd?

Tejnaksh Healthcare Ltd has a price-to-earnings (PE) ratio of 12.5 in the Healthcare sector.

What is the market capitalisation of Tejnaksh Healthcare Ltd?

Tejnaksh Healthcare Ltd has a market capitalisation of approximately ₹29 crore.

Tejnaksh Healthcare Ltd

TEJNAKSH·BSE·Healthcare

₹14.40▲ +0.12 (+0.84%)

Healthcare · Healthcare Services

A steady, established business

Day₹14.09

₹14.50

52W₹11

₹2137%

Open

₹14.10

High

₹14.50

Low

₹14.09

Prev Close

₹14.28

Volume

1.6K

VWAP

₹14.29

Snapshot

Key fundamentals

Market Cap

₹29 Cr

P/E Ratio

12.52Cheap

P/B Ratio

1.07

EPS

₹1.15

Book Value

₹13.36

ROE

8.43%Average

ROCE

12.71%Decent

Dividend Yield

0.00%

Debt / Equity

0.01Low

Face Value

₹5.00

52W High

₹20.75

52W Low

₹10.65

Sector

Healthcare

Industry

Healthcare Services

Fairly Valued

None moatMedium uncertainty

Fair value estimate

₹14

▼ 5.2%downside

Trading at ₹14 — 5% above our estimate

BearFair valueBull

₹12₹14₹16

/100

Business quality — Solid

Growth 50Profitability 51Efficiency 24Valuation 97

Plain English

Our view

A steady, established business
Virtually debt-free balance sheet

Strengths

Virtually debt-free balance sheet
Reasonably priced at 13× earnings
Promoters hold a controlling stake

How we got there

Fair value methods

Residual income

8% ROE fading to 12% over ~3 yrs, on ₹13 book

₹13

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹16

Analyst target

No analyst coverage

—

Blended fair value₹14

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Reasonably priced at 13× earnings
Promoters hold a controlling stake

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

12.5Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

8.4%Average

Above 15% is considered healthy for Indian equities

ROCE

12.7%Decent

Above 18% means capital is working hard

Debt/Eq

0.01Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹29 Cr

P/B

1.07

EPS

₹1.15

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

Attractive

P/E 12.5×

Growth

Shrinking

-3% rev CAGR

Profitability

Modest

8.4% ROE

Financial health

Rock solid

D/E 0.01

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹22,549 Cr

Trades13

VWAP₹14.29

Face value₹5.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-2.8%

-2.0%

10Y

+8.6%

Profit

-12.0%

-10.0%

10Y

-0.8%

EPS

+1.6%

-2.9%

10Y

+3.0%

Profile

Pros

Company has reduced debt.
Company is almost debt free.
Stock is trading at 1.07 times its book value

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of -2.04% over past five years.
Company has a low return on equity of 7.22% over last 3 years.
Debtor days have increased from 47.2 to 73.7 days.
Working capital days have increased from 57.9 days to 89.3 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

74%

Promoter

Promoters

73.8%0.00

Public

23.6%-0.14

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

2.6%

Total shareholders

4,414-38 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter73.83%

Public23.58%

Others2.59%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2008, Tejnaksh Healthcare Ltd is in the business of Healthcare Services and Pharmacies[1]